| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C10orf128 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | C1orf198 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | RAB40B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | AC023491.2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | RNF19A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | OR5M11 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | C9orf57 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BZW2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | POLDIP3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | ENHO | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
